ALTEOGEN Inc.

South Korea‑based ALTEOGEN Inc. develops long‑acting biobetters and ADCs using NexP/NexMab tech. Its Phase IIa ALT‑P1 (hGH) and Phase I breast/gastric cancer ALT‑P7 target high‑gap markets, supported by Kissei and Cristalia alliances.

Headquarters: South Korea (KOR)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 159
HQ: Daejeon

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
196170	ALTEOGEN Inc. Cap: 20724.3B	EQUITY	KOE	KRW	KR7196170005	Active	📈